Please update your Flash Player to view content.
The News
Misc. Industry News PDF Print E-mail
(1)
Dr Freda Lewis-Hall Joins Pfizer As Chief Medical Officer Prominent Physician, Researcher and Business Leader Will Direct Global Medical and Regulatory Strategy, Join Executive Leadership Team

NEW YORK, NY, May 4 - Pfizer Inc announced today (04May09) that Freda Lewis-Hall, M.D., has been appointed as Chief Medical Officer and Senior Vice President, Pfizer Inc. Dr. Lewis-Hall will be the senior physician in the company, responsible for enterprise-wide medical, patient safety, regulatory affairs and quality assurance as well as outreach to doctors and other medical professionals. She joins Pfizer from Vertex Pharmaceuticals where she was responsible for clinical and non-clinical development as well as both medical and regulatory.

 
(2)
GlaxoSmithKline plc (GSK) and Pfizer Inc (PFE) today announced they have entered into an agreement to create a new world-leading HIV company focused solely on research, development and commercialisation of HIV medicines. Issued: Thursday 16 April 2009, London UK & Philadelphia, US

http://www.hivfutures.com

  • Creates a new focused HIV business with the independence and sustainability to deliver significant improvements in treatment, access and shareholder value
  • Renews focus on HIV with industry-leading pipeline to deliver more new HIV treatments
  • Equity split of 85% GSK and 15% Pfizer

(3)
GlaxoSmithKline to divest Wellbutrin XL (R) to Biovail in the US for $510 million – (Ref. GlaxoSmithKline; Biovail Bloomberg)

http://www.gsk.com/media/pressreleases/2009/2009_pressrelease_10049.htm

http://www.biovail.com/english/Investor%20Relations/Latest%20News/default.asp?s=1&state=showrelease&releaseid=1284877

http://www.bloomberg.com/apps/news?pid=20601202&sid=aXGPuBY3GqUc&refer=healthcare